Drug Store News

FEBRUARY 27, 2024

SHARx works with uninsured and underinsured Americans, providing their members access to options for high-cost maintenance and specialty medications.

52

52

Fuld

AUGUST 26, 2022

Phronesis Partners and Fuld & Company today announced the appointment of Elaine Pratt to the role of Group Chief Marketing Officer. By: Phronesis Partners and Fuld & Company. ” About Fuld & Company. In this capacity, Elaine will lead the marketing strategy and activities for the two brands.

Communication 52

Communication 52

Drug Store News

DECEMBER 12, 2022

The EmsanaRx Plus supplemental drug discount product represents a transition for Cost Plus Drugs from operating exclusively in the direct-to-consumer market into the employer market.

98

98

Fierce Healthcare

JANUARY 18, 2024

TBD Health, a hybrid sexual health provider, is launching an enterprise offering for digital health companies. | Folx Health will have access to TBD Health’s at-home STD/STI test kits and diagnostics lab, while Wisp will be able to refer to two brick-and-mortar clinics.

71

71

STAT

APRIL 18, 2024

After scouring 200 companies’ pipelines — including a few overlooked pharma shelves — a new company backed by investment firm Population Health Partners and ARCH Venture Partners is launching with one of the most wide-ranging pipelines yet for obesity drug development.

106

106

Drug Store News

SEPTEMBER 14, 2023

Lupin’s Tiotropium Bromide Inhalation Powder, 18 mcg/capsule, is the only generic product available that is therapeutically equivalent to Boehringer Ingelheim’s Spiriva HandiHaler.

98

98

Drug Store News

AUGUST 8, 2023

The collaboration aims to bring lower prescription drug prices to consumers.

98

98

Drug Store News

APRIL 11, 2023

The partnership aims to bring lower prescription drug prices to consumers in the Latino community.

98

98

Pharma Mirror

MARCH 2, 2022

The post Aedesius Health and its lead biopharma company, AO BIO partner with Indegene for a comprehensive commercialization engagement appeared first on Pharma Mirror Magazine. Indegene’s Co-Commercialization model enables Aedesius Health and AO BIO to achieve their mission to reset.

52

52

PharmExec

SEPTEMBER 21, 2023

Celexor Bio expected to focus on ell depletion of pathologic cells in autoimmune and inflammatory disorders.

52

52

Pharmaceutical Commerce

AUGUST 3, 2023

The agreement provides Scripta patients with another option when purchasing medication.

88

88

Pharmaceutical Technology

SEPTEMBER 21, 2023

The licence grants Meitheal marketing rights for insulin aspart, lispro, and glargine following FDA approval.

FDA 59

FDA 59

Fierce Healthcare

MARCH 13, 2024

HiLabs, an AI-powered health tech company helping plans improve member experience, raised $39 million in a series B financing round, led by growth equity firm Denali Growth Partners and VC firm Eig | An AI-powered health tech company helping drive down operational costs for healthcare organizations and improving member experience for payers pocketed (..)

129

129

STAT

APRIL 18, 2024

After a tumultuous experience on the public markets, 23andMe CEO Anne Wojcicki is moving to take the company private. Wojcicki disclosed her plans in a filing with the Securities and Exchange Commission late Wednesday, saying that she intends to seek out potential partners and financiers to help.

108

108

Fierce Pharma

MARCH 25, 2024

officials are pressing the company to pay royalties linked to the commercialization of its lucrative Pfizer-partnered COVID-19 vaccine. . | Even as Germany's BioNTech deals with ongoing declines of its revenue and share price, it's facing another serious concern: U.S.

Vaccines 141

Vaccines 141

Drug Store News

FEBRUARY 3, 2023

The collaboration focuses on pricing transparency, affordable access and engaging cancer patients at home to ensure treatment adherence.

98

98

Pharmaceutical Commerce

APRIL 2, 2024

In this Pharmaceutical Commerce video interview, Joerg Tritschler, a partner in Simon-Kucher’s life sciences division, explores the two major strategies big pharma companies are employing amid current macro challenges and efforts to offset looming patent losses to blockbuster brands.

104

104

STAT

APRIL 15, 2024

Ultragenyx has found early success with its experimental treatment for the rare disease Angelman syndrome, supporting the company’s decision to acquire its development partner two years ago.

Communication 118

Communication 118

Fierce Healthcare

JANUARY 6, 2024

SAN FRANCISCO—Amazon plans to collaborate with digital health companies to connect customers with virtual care benefits for managing conditions like diabetes and hypertension. Amazon plans to collaborate with digital health companies to connect customers with virtual care benefits for managing conditions like diabetes and hypertension.

141

141

Pharmaceutical Commerce

JANUARY 3, 2023

Collaboration aims to decrease environmental burden in the space.

Packaging 52

Packaging 52

pharmaphorum

FEBRUARY 26, 2024

Digital health company Akili expands beyond the US as partner Shionogi files for approval for its ADHD digital therapeutic (DTx) in Japan

117

117

Outsourcing Pharma

APRIL 16, 2024

Bios Health Group, a leading strategic and investment partner for life science companies and investors, has officially introduced the Bios Innovation Circle.

74

74

Pharmaceutical Technology

APRIL 26, 2024

Robotics company Multiply Labs has partnered with global life-sciences service provider GenScript Biotech to automate the cell isolation phase in cell therapy manufacturing.

52

52

STAT

APRIL 9, 2024

  The new company will be led by Daphne Zohar, the founding CEO of the biotech startup foundry PureTech Health, which helped launch both Karuna and Seaport.  

122

122

Drug Store News

JUNE 5, 2023

Mark Cuban Cost Plus Drug Company plans to offer Yusimry to its customers for $569.27, plus dispensing and shipping fees starting in July 2023.

52

52

STAT

NOVEMBER 1, 2023

The firm was founded by Kouki Harasaki, who was previously a partner at M12, Microsoft’s corporate venture group, and Andreessen Horowitz. He also has a track record at pharmaceutical companies like Novartis and Baxalta.

Pharmaceutical Companies 135

Pharmaceutical Companies Pharmaceutical Companies 135

STAT

APRIL 18, 2024

It’s joining with private equity to launch a $4 billion primary care company. Elevance leaders divulged more about the company’s venture with Clayton, Dubilier & Rice on its first quarter earnings call Thursday.

Insurance 103

Insurance 103

Fierce Healthcare

FEBRUARY 29, 2024

Elsevier Health has launched an generative AI-driven version of its flagship clinical decision support tool, ClinicalKey, in partnership with AI company OpenEvidence. | The tool, developed with several key partners, offers an advanced conversational search interface to help doctors find important medical information at the point of care.

125

125

Fierce Healthcare

JANUARY 26, 2024

Cognoa, maker of the first FDA-approved autism diagnostic tool, announced Highmark has signed on as its first commercial payer partner. | The tool, Canvas Dx, leverages AI to empower doctors to quickly and accurately diagnose developmental risk without bias, the company claims. It is the first FDA-approved autism diagnostic tool.

FDA 131

FDA 131

PharmExec

SEPTEMBER 22, 2023

Collaboration aims to cut medication costs for patients with conditions ranging from high blood pressure to diabetes.

52

52

Pharmaceutical Commerce

SEPTEMBER 20, 2023

Collaboration aims to cut medication costs for patients with conditions ranging from high blood pressure to diabetes.

52

52

STAT

SEPTEMBER 21, 2023

Anesthesia Partners and its private equity owner, Welsh, Carson, Anderson & Stowe, alleging in federal court the two partners formed a monopoly in order to drive up prices and boost their profits. Normally, the FTC sues the company that it believes has violated antitrust law. The Federal Trade Commission has sued U.S.

Insurance 145

Insurance Hospitals 145

STAT

JANUARY 8, 2024

SAN FRANCISCO — Mayo Clinic has signed Silicon Valley tech startup Cerebras as its first generative AI partner, the health system announced Monday. health system. The deal gives Mayo access to Cerebras’ supercomputers as well as a Cerebras team to help develop health-tuned models; Mayo will then own whatever they build.

Mayo Clinic 132

Mayo Clinic 132

Fierce Healthcare

FEBRUARY 29, 2024

The nonprofit health system partnered with Health Catalyst on eight years of performance improvement initiatives targeting length of stay, care management, ED utilization and other costly focus areas. The data analytics company's CEO attributes the gains to UnityPoint's commitment to a platform approach over point solutions.

125

125

Fierce Healthcare

APRIL 11, 2024

NeueHealth relinquished control of 10% of its company to raise up to $30 million from investment partner New Enterprise Associates. Just days after issuing executive bonuses for hitting performance measures, NeueHealth increased its loan commitment on its amended credit facility by $30 million.

74

74

PharmExec

APRIL 23, 2024

In this Pharmaceutical Executive video interview, Jon Hamrick, Partner, Curatio Scientia Advisors and Jon Rawlson, President & Founder, Armory Hill Advocates, discuss what’s stopping companies from investing in covering state level legislation and regulations impacting patient services, access, and affordability.

52

52

Fierce Healthcare

FEBRUARY 2, 2024

When Florida Blue announced this week that it’s partnering with Sanitas Medical Center in Jacksonville to deliver primary care, officials with the company considered it in keeping with a healthcare | Among the primary care services to be offered at Sanitas Medical Center in Jacksonville are onsite pharmacy dispensing, chronic condition management, (..)

110

110